Katrine Jordan Schjødt

Research fellow

Education
Jun 2001 Medical Science Final Exam at University of Copenhagen

Previous employments

Apr2000- Sep2000	Temporary Physician, Medical Department, Gastroenterology Clinic, KAS Glostrup
Okt01 - Apr02	Staff Physician, residency rotation, Cardiology Clinic, H:S Amager hospital
Apr02 - Okt02	Staff Physician, residency rotation, Orthopedic surgery department, H:S Amager hospital
Okt02- Apr03	Staff Physician (specialist training), residency rotation, with general practitioner specialist, Anne Hagensen
May03	Employed as Scientific Assistant, Steno Diabetes Center

Scientific publications
Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving H-H. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia (2004) 47:1936-1939

Schjoedt KJ, Jacobsen P, Rossing K, Boomsma F, Parving H-H. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone. Horm Metab Res. 2005 Apr;37 Suppl 1:4-8.

Rossing K, Schjoedt KJ, Smidt UM, Boomsma F, Parving H-H. Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study. Diabetes Care. 2005 Sep;28(9):2106-12.

Rossing K, Schjoedt KJ, Jensen BR, Boomsma F, Parving H-H. Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney Int. 2005 Sep;68(3):1190-8.

Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Rossing P, Tarnow L, Parving H-H. Beneficial impact of spironolactone in Diabetic Nephropathy. Kidney Int. 2005 Dec;68(6):2829-36.

Schjoedt KJ, Lajer M, Andersen S, Tarnow L, Rossing P, Parving H-H. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy. Scand J Clin Lab Invest. 2006;66(3):173-80.

Lajer M, Schjoedt KJ, Jacobsen P, Tarnow L, Parving H-H. Aldosterone synthase (CYP11B2) -344T/C polymorphism is not associated with the initiation and progression of diabetic nephropathy in Caucasian Type 1 diabetic patients. Diabet Med. 2006 Jun;23(6):675-80.

Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Tarnow L, Rossing P, Parving H-H. Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy.
Kidney Int. 2006 Aug;70(3):536-42.

GCP-experience
Has completed the course: “GCP and Investigator-initiated Clinical trials” and has participated in the conduction of clinical trials according to GCP regulations.